| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA880305 | A | Oral bioavailability of compound after administration of a solution dose in PEG400 | Eutheria | 1 | ALA1141103 | organism-based format | Scientific Literature | |
| 2. | ALA880480 | A | Half-life of compound evaluated in mice after intravenous administration | Mus musculus | 1 | ALA1141103 | organism-based format | Scientific Literature | |
| 3. | ALA881417 | A | Clearance of compound in mice after intravenous administration | Mus musculus | 1 | ALA1141103 | organism-based format | Scientific Literature | |
| 4. | ALA881421 | A | In vitro permeability of compound into Caco-2 cells | Homo sapiens | 1 | ALA1141103 | cell-based format | Scientific Literature | |
| 5. | ALA881431 | A | Metabolic rate as a measure of compound stability in rat liver microsomes | Rattus norvegicus | 1 | ALA1141103 | microsome format | Scientific Literature | |
| 6. | ALA881432 | A | Metabolic rate as a measure of compound stability in human liver microsomes | Homo sapiens | 1 | ALA1141103 | microsome format | Scientific Literature | |
| 7. | ALA872286 | B | Binding affinity for human p38 MAP kinase expressed in Escherichia coli using [gamma-33P]ATP; n=4 | Homo sapiens | 16 | ALA1141103 | assay format | Scientific Literature | |
| 8. | ALA856248 | F | Concentration required to inhibit LPS-induced TNFalpha production in human peripheral blood mononuclear cells; n=3 | Homo sapiens | 16 | ALA1141103 | cell-based format | Scientific Literature | |
| 9. | ALA883605 | F | In vitro cytotoxic effect of compound (30 uM) on PHA blast cells compared to control after 24 hours of treatment | Homo sapiens | 1 | ALA1141103 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!